Hi Varky,
You can start at looking the company website.About Cymerus
The trademark Cymerus refers to the patented process of generating cell-based products from intermediate cells, known as mesenchymoangioblasts (MCAs), which in turn are derived from induced pluripotent stem cells (iPSCs). This technology was originally developed at the University of Wisconsin-Madison (UWM), a world-renowned leader in stem cell research.
The means of producing MCAs from pluripotent precursors, and the defining pattern of MCA cell surface markers, are the subjects of US patent 7,615,374, and a number of other patent applications in process around the world, licensed to or owned by Cynata.
At present, Cynata is focussed on the production of mesenchymal stem cell (MSC)-based products using the Cymerus technology.
https://www.cynata.com/about-cymerus
https://www.cynata.com/
Regards
Rossi70
Ann: Quarterly Activity Report & Appendix 4C, page-48
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.91M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.0¢ | 21.0¢ | $24.71K | 115.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 33964 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 2000 | 1 |
View Market Depth
| Last trade - 15.41pm 09/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |